Production Method 1

6779-87-9

6779-87-9

22150-76-1

948-60-7

712-30-1

Reaction Conditions

1.1 Reagents: Oxygen Solvents: Water

Reference

Photochemistry of dihydrobiopterin in aqueous solution

Vignoni, Mariana; Cabrerizo, Franco M.; Lorente, Carolina; Claparols, Catherine; Oliveros, Esther; et al, Organic & Biomolecular Chemistry, 2010, 8(4), 800-810

7,8-Dihydro-L-biopterin Raw materials

• 7,8-Dihydro-L-biopterin

7,8-Dihydro-L-biopterin Preparation Products

• 6-Biopterin (22150-76-1)
• Pterine-6-carboxylic Acid (948-60-7)
• 6-Pteridinecarboxaldehyde,2-amino-3,4-dihydro-4-oxo- (712-30-1)
• 7,8-Dihydro-L-biopterin (6779-87-9)

• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 3. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 4. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pteridines and derivatives Biopterins and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pteridines and derivatives Pterins and derivatives Biopterins and derivatives

Comprehensive Overview of 7,8-Dihydro-L-biopterin (CAS No. 6779-87-9): Functions, Applications, and Research Insights

7,8-Dihydro-L-biopterin (CAS No. 6779-87-9) is a pivotal intermediate in the biosynthesis of tetrahydrobiopterin (BH4), a cofactor essential for enzymatic reactions involving aromatic amino acid hydroxylases and nitric oxide synthases. This compound has garnered significant attention in biochemical and medical research due to its role in neurotransmitter synthesis, cellular redox balance, and endothelial function. Researchers and healthcare professionals frequently explore its implications in conditions like phenylketonuria (PKU), cardiovascular diseases, and neurodegenerative disorders.

The structural uniqueness of 7,8-Dihydro-L-biopterin lies in its pteridine ring system, which facilitates electron transfer during enzymatic processes. Its derivative, BH4, is critical for the proper functioning of enzymes such as phenylalanine hydroxylase (PAH) and tyrosine hydroxylase (TH). Deficiencies in BH4 metabolism are linked to rare genetic disorders, making 7,8-Dihydro-L-biopterin a focal point for therapeutic development. Recent studies also highlight its potential in mitochondrial health and anti-aging research, aligning with growing public interest in longevity science.

In the realm of supplementation and nutraceuticals, 7,8-Dihydro-L-biopterin is often discussed alongside coenzyme Q10 and NAD+ precursors for their synergistic effects on energy metabolism. Online searches frequently include queries like "7,8-Dihydro-L-biopterin benefits" or "BH4 supplementation for cognitive health", reflecting consumer curiosity about its non-pharmaceutical applications. However, its instability under oxidative conditions necessitates advanced formulation techniques, a topic explored in pharmaceutical technology journals.

From an industrial perspective, CAS No. 6779-87-9 is synthesized through multi-step chemical or enzymatic processes, with purity being paramount for research-grade applications. Analytical methods such as HPLC and mass spectrometry are employed to verify its integrity, as impurities may affect experimental outcomes. The compound's shelf life and storage conditions (typically at -20°C under inert atmosphere) are critical considerations for laboratories.

Emerging trends connect 7,8-Dihydro-L-biopterin to personalized medicine, particularly in metabolomics profiling for individuals with mood disorders or mitochondrial dysfunction. Its interplay with nitric oxide signaling has also spurred investigations into vascular health supplements, often marketed as "endothelial support" formulations. Despite promising data, regulatory agencies emphasize the need for more clinical trials to substantiate efficacy claims.

Environmental and sustainability aspects of producing 7,8-Dihydro-L-biopterin are gaining traction, with green chemistry approaches being developed to reduce waste in synthesis. This aligns with broader industry shifts toward eco-friendly biomolecules, a frequently searched topic among biotech entrepreneurs and academic researchers.

In summary, 7,8-Dihydro-L-biopterin (CAS No. 6779-87-9) bridges fundamental biochemistry and applied health sciences. Its multifaceted roles—from enzyme cofactor to potential therapeutic agent—make it a compound of enduring scientific and commercial interest. Ongoing research continues to unravel its mechanisms, offering opportunities for innovation in biopharmaceuticals and precision nutrition.

• 17094-01-8(L-Sepiapterin)
• 3672-03-5(2-amino-7,8-dihydro-6-(hydroxymethyl)-4(3H)-Pteridinone)
• 37557-79-2(2-amino-7,8-dihydro-6-(hydroxymethyl)-7,7-dimethyl-4(3H)-Pteridinone)
• 1218-98-0(7,8-Dihydroneopterin)
• 75762-47-9(Hydroxysepiapterin)
• 17377-13-8(2-amino-7,8-dihydro-6-methyl-4(3H)-Pteridinone)
• 490-58-4(4,7(1H,8H)-Pteridinedione,2-amino-6-(1,2-dihydroxypropyl)- (9CI))
• 41230-32-4(4(3H)-Pteridinone,2-amino-6-(2,3-dihydroxy-1-oxopropyl)-7,8-dihydro-)
• 89157-13-1(4(1H)-Pteridinone, 2-amino-6-ethyl-7,8-dihydro-7-methyl-)
• 63954-27-8(4(3H)-Pteridinone,2-amino-7,8-dihydro-6-(2-hydroxypropyl)-8-methyl-)